DOCSLIB.ORG

A Novel DSF-Like Signal from Burkholderia Cenocepacia Interferes with Candida Albicans Morphological Transition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Novel DSF-Like Signal from Burkholderia Cenocepacia Interferes with Candida Albicans Morphological Transition The ISME Journal (2008) 2, 27–36 & 2008 International Society for Microbial Ecology All rights reserved 1751-7362/08 $30.00 www.nature.com/ismej ORIGINAL ARTICLE A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition Calvin Boon1,3, Yinyue Deng1,2,3, Lian-Hui Wang1, Yawen He1, Jin-Ling Xu1, Yang Fan1, Shen Q Pan2 and Lian-Hui Zhang1,2 1Institute of Molecular and Cell Biology, Singapore and 2Department of Biological Sciences, National University of Singapore, Singapore In addition to producing lethal antibiotics, microorganisms may also use a new form of antagonistic mechanism in which signal molecules are exported to influence the gene expression and hence the ecological competence of their competitors. We report here the isolation and characterization of a novel signaling molecule, cis-2-dodecenoic acid (BDSF), from Burkholderia cenocepacia. BDSF is structurally similar to the diffusible signal factor (DSF) that is produced by the RpfF enzyme of Xanthomonas campestris. Deletion analysis demonstrated that Bcam0581, which encodes an RpfF homologue, was essential for BDSF production. The gene is highly conserved and widespread in the Burkholderia cepacia complex. Exogenous addition of BDSF restored the biofilm and extracellular polysaccharide production phenotypes of Xanthomonas campestris pv. campestris DSF-deficient mutants, highlighting its potential role in inter-species signaling. Further analyses showed that Candida albicans germ tube formation was strongly inhibited by either coculture with B. cenocepacia or by exogenous addition of physiological relevant levels of BDSF, whereas deletion of Bcam0581 abrogated the inhibitory ability of the bacterial pathogen. As B. cenocepacia and C. albicans are frequently encountered human pathogens, identification of the BDSF signal and its activity thus provides a new insight into the molecular grounds of their antagonistic interactions whose importance to microbial ecology and pathogenesis is now becoming evident. The ISME Journal (2008) 2, 27–36; doi:10.1038/ISMEJ.2007.76; published online 29 November 2007 Subject Category: microbe-microbe and microbe-host interactions Keywords: BDSF; DSF; quorum sensing; signal interference; antagonism Introduction microorganisms appear to produce, release and respond collectively to species-specific small signal Microbe–microbe interactions are ubiquitous in molecules to coordinate a range of important various natural ecosystems. Not surprisingly, var- activities, such as virulence factor production, ious forms of symbiosis and antagonism have antibiotics biosynthesis and biofilm formation. This surfaced. It has been known for a long time that cell–cell communication mechanism is commonly microorganisms may produce antibiotics to inhibit known as quorum sensing (Whitehead et al., 2001; or stop the growth of their competitors to gain Fuqua and Greenberg, 2002). Logically, microorgan- competitive advantages. Recently, evidence is accu- isms might also boost their competitive strength in mulating for a new form of microbial antagonism, ecosystems by interfering with the quorum-sensing which was tentatively designated as signal inter- signaling of their competitors (Zhang and Dong, ference (Zhang and Dong, 2004). This type of 2004). antagonism acts not by killing, but instead by Candida albicans causes various forms of candia- influencing the signal-mediated gene expression of sis ranging from mucosal infections to serious the competitors and thus tips the balance of systemic infections. Mutants defective in morpho- interaction (Dong et al., 2004; Hogan et al., 2004). logical transitions during infection are avirulent For keeping up their competitive advantages, many (Lo et al., 1997; Braun et al., 2000; Saville et al., 2003; Zheng et al., 2003). Therefore, this ability to switch between yeast and hyphal-form is an im- Correspondence: L-H Zhang, Institute of Molecular and Cell portant aspect of its pathogenesis. Intriguingly, the Biology, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore. chance of infection by C. albicans seems to be E-mail: [email protected] 3These authors have contributed equally to this work. influenced by the presence of certain bacterial Received 2 July 2007; revised 27 August 2007; accepted 27 August pathogens. While the fungal pathogen can be found 2007; published online 29 November 2007 in various groups of patients who have undergone A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans C Boon et al 28 treatments with broad-spectrum antibiotics, it is grown either in GMM medium consisting of 6.7 g of rarely found in individuals suffering from cystic Bacto yeast nitrogen base (Difco, Sparks, MD, USA) fibrosis that are chronically infected with Pseudo- and 0.2% glucose or in minimum medium (pH 7.2). monas aeruginosa and Burkholderia cepacia (Kerr, The latter consists of K2PO4,60mM;KH2PO4,30mM; 1994). This putative antagonism seems to be at least citrate, 20 mM; (NH4)2SO4,15mM; MgSO4 Á 7H2O, partially explained by the recent finding that the 0.8 mM; CaCl2,90mM;FeSO4,30mM;MnCl2,15mM; long-chain quorum-sensing signal 3-oxo-C12HSL and Casamino acids, 0.5%. DSF was added to the produced by P. aeruginosa at physiological relevant medium in a final concentration of 5 mM unless level was sufficient to inhibit C. albicans yeast-to- otherwise indicated. hyphae transition (Hogan et al., 2004). However, C8- HSL, the major quorum-sensing signal produced by B. cepacia (Lewenza et al., 1999; Riedel et al., 2001), Bioassay of BDSF was not able to suppress the fungal filamentation The assay was performed as described previously (Hogan et al., 2004). using the biosensor strain FE58 (Wang et al., 2004). Burkholderia cepacia complex (Bcc) has emerged Briefly, 4-mm diameter wells were introduced on as a major opportunist pathogen for immunocom- prepared bioassay plates and 20 ml concentrated promised individuals in particular the patients with culture was added to each well. Alternatively, single cystic fibrosis and chronic granulomatous disease colonies were spotted on bioassay plates. The plates (Isles et al., 1984; Goldmann and Klinger, 1986; were incubated at 30 1C overnight. DSF activity is Mahenthiralingam et al., 2005). The Bcc consist of at indicated by the presence of a blue halo around the least nine species that are phenotypically similar well or colony. but genetically distinct, and all the species are capable of causing infections (Coenye et al., 2001; Mahenthiralingam et al., 2005). Among them, Burkholderia cenocepacia constitutes the majority BDSF purification of the transmissible and epidemic strains and is B. cenocepacia J2315 was grown in LB overnight 1 highly virulent (Mahenthiralingam et al., 2001, with agitation at 37 C. Seventy liters of culture 2002). In this study, we report the identification supernatant was collected by centrifugation and and characterization of a novel signaling molecule extracted with equal volume of ethyl acetate. The designated as BDSF from B. cenocepacia. BDSF is a crude extract (organic phase) was dried using a structural homologue of diffusible signal factor rotary evaporator and dissolved with methanol. The (DSF), which is the quorum-sensing signal produced mixture was subjected to flash column chromato- by the plant bacterial pathogen Xanthomonas graphy using a silica gel column (12 Â 150 mm, campestris pv. campestris (Xcc). In addition, we Biotage Flash 12 M cartridge) and eluted with ethyl demonstrate that the ORF Bcam0581 is essential for acetate–hexane (20:80 v/v). The active fractions BDSF production and can genetically substitute for were detected using the DSF bioassay and pooled. the DSF synthase gene rpfF in Xcc. Furthermore, we These were then concentrated, subjected to flash show that the dimorphic transition of C. albicans column chromatography again and eluted with ethyl was inhibited by either exogenous addition of BDSF acetate–hexane (10:90 v/v). The purity of the col- or coculturing with B. cenocepacia. lected active components was analyzed by high- performance liquid chromatography using a C18 reverse-phase column (4.8 Â 250 mm, Waters, Milford, MA, USA), eluted with methanol–water Materials and methods (80:20 v/v) at a flow rate of 1 ml minÀ1. Bacteria strains and growth conditions B. cenocepacia J2315, a cystic fibrosis clinical isolate, was obtained from the American Type Structure analysis and synthesis of BDSF Culture Collection, Manassas, VA, USA. It is the 1H, 13C, 1H-1H COSY, distortionless enhancement by representative strain of the highly transmissible polarization transfer, heteronuclear multiple bond ET12 clone (Govan et al., 1993). X. campestris pv. coherence and heteronuclear multiple quantum campestris strain 8004 and its rpfF deletion mutant coherence (HMQC) nuclear magnetic resonance 8004dF were described previously (Wang et al., (NMR) spectra in CDCl3 solution were obtained 2004; He et al., 2006b). Xcc strains were maintained using a Bruker DRX400 spectrometer operating at at 30 1C in YEB medium (Zhang et al., 2002), 400 MHz for 1H or 100.5 MHz for 13C. High-resolu- while Escherichia coli and B. cenocepacia strains tion electrospray ionization mass spectrometry was were grown in Luria-Bertani (LB) broth at 37 1C. performed on a Finnigan/MAT MAT 95XL-T mass The following antibiotics were supplemented spectrometer. Conditions used were as stated before when necessary: rifampicin, 50 mgmlÀ1; tetra- (Wang et al., 2004). BDSF was synthesized by cycline, 10
Load more

Recommended publications
  • Crystal Structures of the Burkholderia Multivorans Hopanoid Transporter Hpnn
    Crystal structures of the Burkholderia multivorans hopanoid transporter HpnN Nitin Kumara,1, Chih-Chia Sub,1, Tsung-Han Choub, Abhijith Radhakrishnana, Jared A. Delmarb, Kanagalaghatta R. Rajashankarc,d, and Edward W. Yua,b,2 aDepartment of Chemistry, Iowa State University, Ames, IA 50011; bDepartment of Physics and Astronomy, Iowa State University, IA 50011; cNortheastern Collaborative Access Team, Argonne National Laboratory, Argonne, IL 60439; and dDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14850 Edited by Eric Gouaux, Oregon Health and Science University, Portland, OR, and approved May 15, 2017 (received for review November 30, 2016) Strains of the Burkholderia cepacia complex (Bcc) are Gram-negative critical line of defense against antimicrobial agents in Burkholderia opportunisitic bacteria that are capable of causing serious diseases, species is the permeability barrier of the outer membrane. Most of mainly in immunocompromised individuals. Bcc pathogens are in- these species contain a modified lipopolysaccharide, which results in trinsically resistant to multiple antibiotics, including β-lactams, ami- polymyxin resistance (13). In addition, the permeability of the major noglycosides, fluoroquinolones, and polymyxins. They are major outer membrane porin channel Omp38 appears to be low for an- pathogens in patients with cystic fibrosis (CF) and can cause severe tibiotics (14). The presence of a large number of multidrug efflux necrotizing pneumonia, which is often fatal. Hopanoid biosynthesis pumps, belonging to the resistance-nodulation-cell division (RND) is one of the major mechanisms involved in multiple antimicrobial superfamily, also plays a major role in the intrinsic resistance to a resistance of Bcc pathogens. The hpnN gene of B.
    [Show full text]
  • Austin Ultrahealth Yeast-Free Protocol 1
    1 01/16/12/ Austin UltraHealth Yeast-Free Protocol 1. Follow the Yeast Diet in your binder for 6 weeks or you may also use recipes from the Elimination Diet. (Just decrease the amount of grains and fruits allowed). 2. You will be taking one pill of prescription antifungal daily, for 30 days. This should always be taken two hours away from your probiotics. This medication can be very hard on your liver so it is important to refrain from ALL alcohol while taking this medication. Candida Die-Off Some patients experience die-off symptoms while eliminating the yeast, or Candida, in their gut. Die off symptoms can include the following: Brain fog Dizziness Headache Floaters in the eyes Anxiety/Irritability Gas, bloating and/or flatulence Diarrhea or constipation Joint/muscle pain General malaise or exhaustion What Causes Die-Off Symptoms? The Candida “die-off” occurs when excess yeast in the body literally dies off. When this occurs, the dying yeasts produce toxins at a rate too fast for your body to process and eliminate. While these toxins are not lethal to the system, they can cause an increase in the symptoms you might already have been experiencing. As the body works to detoxify, those Candida die-off symptoms can emerge and last for a matter of days, or weeks. The two main factors which cause the unpleasant symptoms of Candida die off are dietary changes and antifungal treatments, both of which you will be doing. Dietary Changes: When you begin to make healthy changes in your diet, you begin to starve the excess yeasts that have been hanging around, using up the extra sugars in your blood.
    [Show full text]
  • Burkholderia Cenocepacia Integrates Cis-2-Dodecenoic Acid and Cyclic Dimeric Guanosine Monophosphate Signals to Control Virulence
    Burkholderia cenocepacia integrates cis-2-dodecenoic acid and cyclic dimeric guanosine monophosphate signals to control virulence Chunxi Yanga,b,c,d,1, Chaoyu Cuia,b,c,1, Qiumian Yea,b, Jinhong Kane, Shuna Fua,b, Shihao Songa,b, Yutong Huanga,b, Fei Hec, Lian-Hui Zhanga,c, Yantao Jiaf, Yong-Gui Gaod, Caroline S. Harwoodb,g,2, and Yinyue Denga,b,c,2 aState Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, South China Agricultural University, Guangzhou 510642, China; bGuangdong Innovative Research Team of Sociomicrobiology, College of Agriculture, South China Agricultural University, Guangzhou 510642, China; cIntegrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China; dSchool of Biological Sciences, Nanyang Technological University, Singapore 637551; eCenter for Crop Germplasm Resources, Institute of Crop Sciences, Chinese Academy of Agricultural Sciences, Beijing 100081, China; fState Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; and gDepartment of Microbiology, University of Washington, Seattle, WA 98195 Contributed by Caroline S. Harwood, October 30, 2017 (sent for review June 1, 2017; reviewed by Maxwell J. Dow and Tim Tolker-Nielsen) Quorum sensing (QS) signals are used by bacteria to regulate N-octanoyl homoserine lactone (C8-HSL). The two QS systems biological functions in response to cell population densities. Cyclic have both distinct and overlapping effects on gene expression diguanosine monophosphate (c-di-GMP) regulates cell functions in (16, 17). response to diverse environmental chemical and physical signals One of the ways in which QS systems can act is by controlling that bacteria perceive. In Burkholderia cenocepacia, the QS signal levels of intracellular cyclic diguanosine monophosphate (c-di-GMP) receptor RpfR degrades intracellular c-di-GMP when it senses the in bacteria (18–21).
    [Show full text]
  • Candida Auris
    microorganisms Review Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities Suhail Ahmad * and Wadha Alfouzan Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait; [email protected] * Correspondence: [email protected]; Tel.: +965-2463-6503 Abstract: Candida auris, a recently recognized, often multidrug-resistant yeast, has become a sig- nificant fungal pathogen due to its ability to cause invasive infections and outbreaks in healthcare facilities which have been difficult to control and treat. The extraordinary abilities of C. auris to easily contaminate the environment around colonized patients and persist for long periods have recently re- sulted in major outbreaks in many countries. C. auris resists elimination by robust cleaning and other decontamination procedures, likely due to the formation of ‘dry’ biofilms. Susceptible hospitalized patients, particularly those with multiple comorbidities in intensive care settings, acquire C. auris rather easily from close contact with C. auris-infected patients, their environment, or the equipment used on colonized patients, often with fatal consequences. This review highlights the lessons learned from recent studies on the epidemiology, diagnosis, pathogenesis, susceptibility, and molecular basis of resistance to antifungal drugs and infection control measures to combat the spread of C. auris Citation: Ahmad, S.; Alfouzan, W. Candida auris: Epidemiology, infections in healthcare facilities. Particular emphasis is given to interventions aiming to prevent new Diagnosis, Pathogenesis, Antifungal infections in healthcare facilities, including the screening of susceptible patients for colonization; the Susceptibility, and Infection Control cleaning and decontamination of the environment, equipment, and colonized patients; and successful Measures to Combat the Spread of approaches to identify and treat infected patients, particularly during outbreaks.
    [Show full text]
  • Candida Species Identification by NAA
    Candida Species Identification by NAA Background Vulvovaginal candidiasis (VVC) occurs as a result of displacement of the normal vaginal flora by species of the fungal genus Candida, predominantly Candida albicans. The usual presentation is irritation, itching, burning with urination, and thick, whitish discharge.1 VVC accounts for about 17% to 39% of vaginitis1, and most women will be diagnosed with VVC at least once during their childbearing years.2 In simplistic terms, VVC can be classified into uncomplicated or complicated presentations. Uncomplicated VVC is characterized by infrequent symptomatic episodes, mild to moderate symptoms, or C albicans infection occurring in nonpregnant and immunocompetent women.1 Complicated VVC, in contrast, is typified by severe symptoms, frequent recurrence, infection with Candida species other than C albicans, and/or occurrence during pregnancy or in women with immunosuppression or other medical conditions.1 Diagnosis and Treatment of VVC Traditional diagnosis of VVC is accomplished by either: (i) direct microscopic visualization of yeast-like cells with or without pseudohyphae; or (ii) isolation of Candida species by culture from a vaginal sample.1 Direct microscopy sensitivity is about 50%1 and does not provide a species identification, while cultures can have long turnaround times. Today, nucleic acid amplification-based (NAA) tests (eg, PCR) for Candida species can provide high-quality diagnostic information with quicker turnaround times and can also enable investigation of common potential etiologies
    [Show full text]
  • Candida & Nutrition
    Candida & Nutrition Presented by: Pennina Yasharpour, RDN, LDN Registered Dietitian Dickinson College Kline Annex Email: [email protected] What is Candida? • Candida is a type of yeast • Most common cause of fungal infections worldwide Candida albicans • Most common species of candida • C. albicans is part of the normal flora of the mucous membranes of the respiratory, gastrointestinal and female genital tracts. • Causes infections Candidiasis • Overgrowth of candida can cause superficial infections • Commonly known as a “yeast infection” • Mouth, skin, stomach, urinary tract, and vagina • Oropharyngeal candidiasis (thrush) • Oral infections, called oral thrush, are more common in infants, older adults, and people with weakened immune systems • Vulvovaginal candidiasis (vaginal yeast infection) • About 75% of women will get a vaginal yeast infection during their lifetime Causes of Candidiasis • Humans naturally have small amounts of Candida that live in the mouth, stomach, and vagina and don't cause any infections. • Candidiasis occurs when there's an overgrowth of the fungus RISK FACTORS WEAKENED ASSOCIATED IMUMUNE SYSTEM FACTORS • HIV/AIDS (Immunosuppression) • Infants • Diabetes • Elderly • Corticosteroid use • Antibiotic use • Contraceptives • Increased estrogen levels Type 2 Diabetes – Glucose in vaginal secretions promote Yeast growth. (overgrowth) Treatment • Antifungal medications • Oral rinses and tablets, vaginal tablets and suppositories, and creams. • For vaginal yeast infections, medications that are available over the counter include creams and suppositories, such as miconazole (Monistat), ticonazole (Vagistat), and clotrimazole (Gyne-Lotrimin). • Your doctor may prescribe a pill, fluconazole (Diflucan). The Candida Diet • Avoid carbohydrates: Supporters believe that Candida thrives on simple sugars and recommend removing them, along with low-fiber carbohydrates (eg, white bread).
    [Show full text]
  • Burkholderia Cenocepacia Intracellular Activation of the Pyrin
    Activation of the Pyrin Inflammasome by Intracellular Burkholderia cenocepacia Mikhail A. Gavrilin, Dalia H. A. Abdelaziz, Mahmoud Mostafa, Basant A. Abdulrahman, Jaykumar Grandhi, This information is current as Anwari Akhter, Arwa Abu Khweek, Daniel F. Aubert, of September 29, 2021. Miguel A. Valvano, Mark D. Wewers and Amal O. Amer J Immunol 2012; 188:3469-3477; Prepublished online 24 February 2012; doi: 10.4049/jimmunol.1102272 Downloaded from http://www.jimmunol.org/content/188/7/3469 Supplementary http://www.jimmunol.org/content/suppl/2012/02/24/jimmunol.110227 Material 2.DC1 http://www.jimmunol.org/ References This article cites 71 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/188/7/3469.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 29, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Activation of the Pyrin Inflammasome by Intracellular Burkholderia cenocepacia Mikhail A.
    [Show full text]
  • GRAS Notice for Pichia Kudriavzevii ASCUSDY21 for Use As a Direct Fed Microbial in Dairy Cattle
    GRAS Notice for Pichia kudriavzevii ASCUSDY21 for Use as a Direct Fed Microbial in Dairy Cattle Prepared for: Division of Animal Feeds, (HFV-220) Center for Veterinary Medicine 7519 Standish Place Rockville, Maryland 20855 Submitted by: ASCUS Biosciences, Inc. 6450 Lusk Blvd Suite 209 San Diego, California 92121 GRAS Notice for Pichia kudriavzevii ASCUSDY21 for Use as a Direct Fed Microbial in Dairy Cattle TABLE OF CONTENTS PART 1 – SIGNED STATEMENTS AND CERTIFICATION ................................................................................... 9 1.1 Name and Address of Organization .............................................................................................. 9 1.2 Name of the Notified Substance ................................................................................................... 9 1.3 Intended Conditions of Use .......................................................................................................... 9 1.4 Statutory Basis for the Conclusion of GRAS Status ....................................................................... 9 1.5 Premarket Exception Status .......................................................................................................... 9 1.6 Availability of Information .......................................................................................................... 10 1.7 Freedom of Information Act, 5 U.S.C. 552 .................................................................................. 10 1.8 Certification ................................................................................................................................
    [Show full text]
  • Characterization of the Burkholderia Cenocepacia J2315 Surface-Exposed Immunoproteome
    Article Characterization of the Burkholderia cenocepacia J2315 Surface-Exposed Immunoproteome 1, 1, 1, Sílvia A. Sousa * , António M.M. Seixas y , Manoj Mandal y, Manuel J. Rodríguez-Ortega 2 and Jorge H. Leitão 1,* 1 iBB–Institute for Bioengineering and Biosciences, 1049-001 Lisbon, Portugal; [email protected] (A.M.M.S.); [email protected] (M.M.) 2 Departament of Biochemistry and Molecular Biology, Córdoba University, 14071 Córdoba, Spain; [email protected] * Correspondence: [email protected] (S.A.S.); [email protected] (J.H.L.); Tel.: +351-2184-19986 (S.A.S.); +351-2184-17688 (J.H.L.) Both authors contributed equally to the work. y Received: 31 July 2020; Accepted: 3 September 2020; Published: 6 September 2020 Abstract: Infections by the Burkholderia cepacia complex (Bcc) remain seriously life threatening to cystic fibrosis (CF) patients, and no effective eradication is available. A vaccine to protect patients against Bcc infections is a highly attractive therapeutic option, but none is available. A strategy combining the bioinformatics identification of putative surface-exposed proteins with an experimental approach encompassing the “shaving” of surface-exposed proteins with trypsin followed by peptide identification by liquid chromatography and mass spectrometry is here reported. The methodology allowed the bioinformatics identification of 263 potentially surface-exposed proteins, 16 of them also experimentally identified by the “shaving” approach. Of the proteins identified, 143 have a high probability of containing B-cell epitopes that are surface-exposed. The immunogenicity of three of these proteins was demonstrated using serum samples from Bcc-infected CF patients and Western blotting, validating the usefulness of this methodology in identifying potentially immunogenic surface-exposed proteins that might be used for the development of Bcc-protective vaccines.
    [Show full text]
  • Vaginal Yeast Infection a Vaginal Yeast Infection Is an Infection of the Vagina, Most Commonly Due to the Fungus Candida Albicans
    5285 Anthony Wayne Drive, Detroit, MI 48202 (P) 313-577-5041 | (F) 313-577-9581 health.wayne.edu Vaginal Yeast Infection A vaginal yeast infection is an infection of the vagina, most commonly due to the fungus Candida albicans. Causes, incidence, and risk factors Most women have a vaginal yeast infection at some time. Candida albicans is a common type of fungus. It is often found in small amounts in the vagina, mouth, digestive tracts, and on the skin. Usually it does not cause disease or symptoms. Candida and the many other germs that normally live in the vagina keep each other in balance. However, sometimes the number of Candida albicans increases, leading to a yeast infection. A yeast infection can happen if you are: • Taking antibiotics used to treat other types of infections. Antibiotics change the normal balance between germs in the vagina by decreasing the number of protective bacteria. • Pregnant • Obese • Have diabetes A yeast infection is not a sexually transmitted illness. However, some men will develop symptoms such as itching and a rash on the penis after having sexual contact with an infected partner. Having many vaginal yeast infections may be a sign of other health problems. Other vaginal infections and discharges can be mistaken for vaginal yeast infection. Symptoms • Pain with intercourse • Painful urination • Redness and swelling of the vulva • Vaginal and labial itching, burning • Abnormal Vaginal Discharge • Ranges from a slightly watery, white discharge to a thick, white, chunky discharge (like cottage cheese) Signs and Tests A pelvic examination will be done. It may show swelling and redness of the skin of the vulva, in the vagina, and on the cervix.
    [Show full text]
  • Targeting the Burkholderia Cepacia Complex
    viruses Review Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex Philip Lauman and Jonathan J. Dennis * Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-780-492-2529 Abstract: The increasing prevalence and worldwide distribution of multidrug-resistant bacterial pathogens is an imminent danger to public health and threatens virtually all aspects of modern medicine. Particularly concerning, yet insufficiently addressed, are the members of the Burkholderia cepacia complex (Bcc), a group of at least twenty opportunistic, hospital-transmitted, and notoriously drug-resistant species, which infect and cause morbidity in patients who are immunocompromised and those afflicted with chronic illnesses, including cystic fibrosis (CF) and chronic granulomatous disease (CGD). One potential solution to the antimicrobial resistance crisis is phage therapy—the use of phages for the treatment of bacterial infections. Although phage therapy has a long and somewhat checkered history, an impressive volume of modern research has been amassed in the past decades to show that when applied through specific, scientifically supported treatment strategies, phage therapy is highly efficacious and is a promising avenue against drug-resistant and difficult-to-treat pathogens, such as the Bcc. In this review, we discuss the clinical significance of the Bcc, the advantages of phage therapy, and the theoretical and clinical advancements made in phage therapy in general over the past decades, and apply these concepts specifically to the nascent, but growing and rapidly developing, field of Bcc phage therapy. Keywords: Burkholderia cepacia complex (Bcc); bacteria; pathogenesis; antibiotic resistance; bacterio- phages; phages; phage therapy; phage therapy treatment strategies; Bcc phage therapy Citation: Lauman, P.; Dennis, J.J.
    [Show full text]
  • Skin Immunity to Candida Albicans
    TREIMM 1284 No. of Pages 11 Feature Review Skin Immunity to Candida albicans Sakeen W. Kashem1 and Daniel H. Kaplan2,* Candida albicans is a dimorphic commensal fungus that colonizes healthy Trends human skin, mucosa, and the reproductive tract. C. albicans is also a predomi- Primary immunodeficiencies reveal nantly opportunistic fungal pathogen, leading to disease manifestations such as conserved IL-17 stimulating/signaling disseminated candidiasis and chronic mucocutaneous candidiasis (CMC). The pathways involved in mucocutaneous differing host susceptibilities for the sites of C. albicans infection have revealed defense against C. albicans. tissue compartmentalization with tailoring of immune responses based on the Mouse models have demonstrated site of infection. Furthermore, extensive studies of host genetics in rare cases of both innate and adaptive sources of IL-17 in response to C. albicans. CMC have identified conserved genetic pathways involved in immune recogni- tion and the response to the extracellular pathogen. We focus here on human Immunity against C. albicans is com- and mouse skin as a site of C. albicans infection, and we review established and partmentalized towards sites of infection. newly discovered insights into the cellular pathways that promote cutaneous antifungal immunity. Non-hematopoietic cells provide anti- fungal immunity in the skin. Compartmentalization of Immunity Against C. albicans Skin Infection C. albicans is the most common and well-studied of the disease-causing Candida spp., and naturally colonizes the skin, genital, and/or intestinal mucosa in up to 70% of healthy individuals [1]. Under normal circumstances, the fungus does not cause disease but the absence of appropriate immune recognition and response mechanisms can lead to the inability to control C.
    [Show full text]